speb/financial-data huggingface dataset:
Financial ratios for IC2.DE — quarterly report dated 2025-06-30
Total revenue: 3262000000
Gross profit: 1829000000
Operating income: 1307000000
Net income: 865000000
Capital expenditures: 167000000
Operating cash flow: 1506000000
Depreciation & amortization: 395000000
Net tangible assets: -18053000000
Owner earnings: 1093000000
Return on net tangible assets (%): -6.054395391347699
Capex to operating income (%): 12.777352716143842
Buffett classification: The Great
Stock price: 120.24705882352941
P/E ratio: 40.54932274997369
Shares outstanding: 565512495
Book value: 28527000000
P/B ratio: 2.383749228860584
Market cap (USD): 68001214251.70589
Debt to equity: 0.6893819889928839
Current ratio: 1.0056291000931048
Quick ratio: 1.0056291000931048
Effective tax rate (%): 23.586572438162545
Interest coverage ratio: 6.502487562189055
COGS to revenue (%): 43.930104230533416
SG&A to revenue (%): 3.893316983445739
Free cash flow (dilution-adjusted): 1281000000
Buyback yield (%): 0.37940498980652804
Retained earnings: 19164000000
Receivables turnover: 1.100168634064081
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5762832137506897
FCF margin (%): 39.27038626609442
Revenue growth (%): 1.0219882316506659
Rule of 40 score: 40.29237449774509
Financial ratios for IC2.DE — quarterly report dated 2025-09-30
Total revenue: 3007000000
Gross profit: 1709000000
Operating income: 1183000000
Net income: 831000000
Capital expenditures: 169000000
Operating cash flow: 915000000
Depreciation & amortization: 387000000
Net tangible assets: -17588000000
Owner earnings: 1049000000
Return on net tangible assets (%): -5.964293836706846
Capex to operating income (%): 14.285714285714285
Buffett classification: The Great
Stock price: 120.24705882352941
P/E ratio: 27.113721790951306
Shares outstanding: 565512495
Book value: 28709000000
P/B ratio: 2.3686375092028937
Market cap (USD): 68001214251.70589
Debt to equity: 0.6795430004528197
Current ratio: 1.011873468478503
Quick ratio: 1.011873468478503
Effective tax rate (%): 23.12673450508788
Interest coverage ratio: 6.161458333333333
COGS to revenue (%): 43.16594612570668
SG&A to revenue (%): 4.622547389424676
Free cash flow (dilution-adjusted): 692000000
Buyback yield (%): 0.5926364763257008
Retained earnings: 19704000000
Receivables turnover: 1.0632956152758133
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.314117485964672
FCF margin (%): 23.012969737279683
Revenue growth (%): -7.817290006131208
Rule of 40 score: 15.195679731148473
Financial ratios for IC2.DE — annual report dated 2025-12-31
Total revenue: 12640000000
Gross profit: 7098000000
Operating income: 4999000000
Net income: 3370000000
Capital expenditures: 791000000
Operating cash flow: 4662000000
Depreciation & amortization: 1560000000
Net tangible assets: -17084000000
Owner earnings: 4139000000
Return on net tangible assets (%): -24.227347225474126
Capex to operating income (%): 15.823164632926584
Buffett classification: The Great
Stock price: 163.12941176470588
P/E ratio: 27.37439782045732
Shares outstanding: 565512495
Book value: 28991000000
P/B ratio: 3.182081358178096
Market cap (USD): 92251720654.94118
Debt to equity: 0.6994929460867165
Current ratio: 1.0197584288363688
Quick ratio: 1.0197584288363688
Effective tax rate (%): 22.457432121491024
Interest coverage ratio: 6.225404732254047
COGS to revenue (%): 43.84493670886076
SG&A to revenue (%): 4.264240506329114
Free cash flow (dilution-adjusted): 3633000000
Buyback yield (%): 1.5143348981265576
Retained earnings: 20281000000
Receivables turnover: 3.9376947040498442
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.473006007087225
FCF margin (%): 28.742088607594933
Revenue growth (%): 7.473854264093189
Rule of 40 score: 36.21594287168812
Financial ratios for IC2.DE — quarterly report dated 2025-12-31
Total revenue: 3142000000
Gross profit: 1781000000
Operating income: 1256000000
Net income: 862000000
Capital expenditures: 266000000
Operating cash flow: 1275000000
Depreciation & amortization: 389000000
Net tangible assets: -17084000000
Owner earnings: 985000000
Return on net tangible assets (%): -5.765628658393819
Capex to operating income (%): 21.17834394904459
Buffett classification: The Great
Stock price: 163.12941176470588
P/E ratio: 27.37439782045732
Shares outstanding: 565512495
Book value: 28991000000
P/B ratio: 3.182081358178096
Market cap (USD): 92251720654.94118
Debt to equity: 0.6994929460867165
Current ratio: 1.0197584288363688
Quick ratio: 1.0197584288363688
Effective tax rate (%): 19.136960600375236
Interest coverage ratio: 6.1568627450980395
COGS to revenue (%): 43.31635900700191
SG&A to revenue (%): 4.328453214513049
Free cash flow (dilution-adjusted): 940000000
Buyback yield (%): 0.43359624856880674
Retained earnings: 20281000000
Receivables turnover: 0.9788161993769471
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3800951280059124
FCF margin (%): 29.917250159134312
Revenue growth (%): 4.489524442966411
Rule of 40 score: 34.406774602100725
Financial ratios for IJ8.DE — annual report dated 2022-04-30
Total revenue: 7033750
Gross profit: -29346250
Operating income: -55920000
Net income: -58367500
Capital expenditures: 4708750
Operating cash flow: -47693750
Depreciation & amortization: 3986250
Net tangible assets: 482340000
Owner earnings: -59090000
Return on net tangible assets (%): -12.250694530828877
Buffett classification: The Gruesome
Stock price: 4.1684210526315795
Shares outstanding: 690201753
Book value: 493691250
P/B ratio: 5.827633197405102
Market cap (USD): 2877051517.7684216
Debt to equity: 0.01809835600691728
Current ratio: 8.450637355622494
Quick ratio: 7.8083344969977455
Interest coverage ratio: -84.09022556390977
COGS to revenue (%): 517.2205438066464
R&D to revenue (%): 24.57792784787631
SG&A to revenue (%): 387.7554647236538
Free cash flow (dilution-adjusted): -62976250
Buyback yield (%): 0
Retained earnings: -220083750
Inventory turnover: 0.9039070749736009
Receivables turnover: 1.6192805755395683
Capitalized R&D asset: 1728750
ROCI (R&D-adjusted, %): -10.701506280851646
FCF margin (%): -895.3438777323619
Rule of 40 score: -895.3438777323619
Financial ratios for IJ8.DE — annual report dated 2023-04-30
Total revenue: 6536250
Gross profit: -98831250
Operating income: -123975000
Net income: -126501250
Capital expenditures: 10691250
Operating cash flow: -90692500
Depreciation & amortization: 4935000
Net tangible assets: 355041250
Owner earnings: -132257500
Return on net tangible assets (%): -37.25130530607359
Buffett classification: The Gruesome
Stock price: 0.978021978021978
Shares outstanding: 690201753
Book value: 369385000
P/B ratio: 1.8274496357548267
Market cap (USD): 675032483.7032967
Debt to equity: 0.026425680523031524
Current ratio: 5.589722260732936
Quick ratio: 4.683334103547607
Interest coverage ratio: -183.3271719038817
COGS to revenue (%): 1612.0481927710846
SG&A to revenue (%): 120.32893478676611
Free cash flow (dilution-adjusted): -111037500
Buyback yield (%): 0
Retained earnings: -345133750
Inventory turnover: 1.432596872875595
Receivables turnover: 2.0594722331626625
Capitalized R&D asset: 1158262.5
ROCI (R&D-adjusted, %): -29.450953024634835
Rosenberg metric: -40.193781634128705
FCF margin (%): -1698.7951807228917
Revenue growth (%): -7.073040696641194
Rule of 40 score: -1705.8682214195328
Financial ratios for IJ8.DE — annual report dated 2024-04-30
Total revenue: 20636250
Gross profit: -20830000
Operating income: -45585000
Net income: -34030000
Capital expenditures: 15555000
Operating cash flow: -63226250
Depreciation & amortization: 7411250
Net tangible assets: 323180000
Owner earnings: -42173750
Return on net tangible assets (%): -13.049616312890649
Buffett classification: The Gruesome
Stock price: 0.6881720430107526
Shares outstanding: 690201753
Book value: 335897500
P/B ratio: 1.4140550330133832
Market cap (USD): 474977550.4516129
Debt to equity: 0.04727632685566281
Current ratio: 4.1676384655274905
Quick ratio: 3.2769942956882487
Interest coverage ratio: -56.715396578538105
COGS to revenue (%): 200.93888182203648
SG&A to revenue (%): 27.1185414016597
Free cash flow (dilution-adjusted): -81466250
Buyback yield (%): 0
Retained earnings: -379048750
Inventory turnover: 0.4710936279591576
Receivables turnover: 1.0303957059043816
Capitalized R&D asset: 570487.5
ROCI (R&D-adjusted, %): -12.180778198316817
FCF margin (%): -394.77254830698405
Revenue growth (%): 215.7200229489386
Rule of 40 score: -179.05252535804544
Financial ratios for IJ8.DE — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 297728571.4285714
Buffett classification: The Gruesome
Stock price: 0.5217391304347826
Shares outstanding: 690201753
Book value: 311968831.16883117
P/B ratio: 1.1542988480150473
Market cap (USD): 360105262.4347826
Debt to equity: 0.052552702567689076
Current ratio: 3.8737788904517942
Quick ratio: 2.9317340078202627
Buyback yield (%): 0
Retained earnings: -430801298.7012987
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IJ8.DE — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 283010666.6666667
Buffett classification: The Gruesome
Stock price: 0.40909090909090906
Shares outstanding: 690201753
Book value: 299006666.6666666
P/B ratio: 0.9443109270392269
Market cap (USD): 282355262.59090906
Debt to equity: 0.05498651089161893
Current ratio: 3.0685535747105313
Quick ratio: 2.463031233445409
Buyback yield (%): 0
Retained earnings: -463698666.6666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IJ8.DE — annual report dated 2025-04-30
Total revenue: 34720000
Gross profit: -31581333.333333332
Operating income: -55281333.333333336
Net income: -60686666.666666664
Capital expenditures: 11354666.666666666
Operating cash flow: -26693333.333333332
Depreciation & amortization: 9841333.333333334
Net tangible assets: 283010666.6666667
Owner earnings: -62199999.99999999
Return on net tangible assets (%): -21.977970206069966
Buffett classification: The Gruesome
Stock price: 0.40909090909090906
Shares outstanding: 690201753
Book value: 299006666.6666666
P/B ratio: 0.9443109270392269
Market cap (USD): 282355262.59090906
Debt to equity: 0.05498651089161893
Current ratio: 3.0685535747105313
Quick ratio: 2.463031233445409
Interest coverage ratio: -42.09238578680203
COGS to revenue (%): 190.96006144393243
SG&A to revenue (%): 11.29800307219662
Free cash flow (dilution-adjusted): -45230666.666666664
Buyback yield (%): 0
Retained earnings: -463698666.6666667
Inventory turnover: 0.8878216000999839
Receivables turnover: 7.690490253987004
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.61983348499
FCF margin (%): -130.2726574500768
Revenue growth (%): 68.24762250893453
Rule of 40 score: -62.025034941142266
Financial ratios for ILI.V — annual report dated 2022-01-31
Total revenue: 0
Operating income: -533043.75
Net income: -388963.28125
Capital expenditures: 0
Operating cash flow: -490673.4375
Net tangible assets: 9963342.96875
Owner earnings: -388963.28125
Return on net tangible assets (%): -3.9039435104259916
Buffett classification: The Gruesome
Stock price: 0.125
Shares outstanding: 340628030
Book value: 9963342.96875
P/B ratio: 4.273515815278805
Market cap (USD): 42578503.75
Debt to equity: 0
Current ratio: 19.20442178345003
Quick ratio: 19.20442178345003
Free cash flow (dilution-adjusted): -490673.4375
Buyback yield (%): 0
Retained earnings: -17465660.9375
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.350049192042173
Rule of 40 score: 0
Financial ratios for ILI.V — annual report dated 2023-01-31
Total revenue: 0
Operating income: -816179.1044776118
Net income: -2465864.925373134
Capital expenditures: 130597.01492537312
Operating cash flow: -431223.13432835817
Net tangible assets: 7985156.71641791
Owner earnings: -2596461.9402985075
Return on net tangible assets (%): -32.51610497462176
Buffett classification: The Gruesome
Stock price: 0.07462686567164178
Shares outstanding: 340628030
Book value: 7985156.7164179105
P/B ratio: 3.183406806098255
Market cap (USD): 25420002.23880597
Debt to equity: 0
Current ratio: 6.134094487617637
Quick ratio: 6.134094487617637
Free cash flow (dilution-adjusted): -776745.5223880596
Buyback yield (%): 0
Retained earnings: -19149481.343283582
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.221203333423674
Rule of 40 score: 0
Financial ratios for ILI.V — annual report dated 2024-01-31
Total revenue: 0
Operating income: -645247.0149253731
Net income: 475646.2686567164
Capital expenditures: 200774.62686567163
Operating cash flow: -855254.4776119402
Net tangible assets: 13300728.358208954
Owner earnings: 274871.64179104473
Return on net tangible assets (%): 2.066590899297626
Buffett classification: The Gruesome
Stock price: 0.029850746268656716
P/E ratio: 21.377232547704146
Shares outstanding: 340628030
Book value: 13300728.358208954
P/B ratio: 0.7644694802933023
Market cap (USD): 10168000.895522388
Debt to equity: 0
Current ratio: 2.4830530649968408
Quick ratio: 2.4830530649968408
Free cash flow (dilution-adjusted): -1056029.1044776118
Buyback yield (%): 0
Retained earnings: -18673835.074626863
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.851215644345816
Rule of 40 score: 0
Financial ratios for ILI.V — quarterly report dated 2024-10-31
Total revenue: 0
Operating income: -101215.8273381295
Net income: 139528.77697841727
Capital expenditures: 104535.9712230216
Operating cash flow: -75123.74100719424
Net tangible assets: 13153355.395683454
Owner earnings: 34992.805755395675
Return on net tangible assets (%): 0.2660371038623292
Buffett classification: The Gruesome
Stock price: 0.02158273381294964
P/E ratio: 13.172343834592281
Shares outstanding: 340628030
Book value: 13153355.395683454
P/B ratio: 0.5589208137059866
Market cap (USD): 7351684.100719425
Debt to equity: 0
Current ratio: 1.248144434545336
Quick ratio: 1.248144434545336
Free cash flow (dilution-adjusted): 1149412.9496402878
Buyback yield (%): 0
Retained earnings: -17671043.884892087
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7695057595063961
Rule of 40 score: 0
Financial ratios for ILI.V — annual report dated 2025-01-31
Total revenue: 0
Operating income: -481192.4137931035
Net income: 185604.1379310345
Capital expenditures: 6573.793103448276
Operating cash flow: -510488.275862069
Net tangible assets: 12477311.724137932
Owner earnings: 179030.3448275862
Return on net tangible assets (%): 1.4348470951578758
Buffett classification: The Gruesome
Stock price: 0.013793103448275864
P/E ratio: 25.313647139258194
Shares outstanding: 340628030
Book value: 12477311.724137932
P/B ratio: 0.3765488719884511
Market cap (USD): 4698317.655172414
Debt to equity: 0
Current ratio: 0.8418187856082855
Quick ratio: 0.8418187856082855
Free cash flow (dilution-adjusted): -2009993.7931034483
Buyback yield (%): 0
Retained earnings: -17071595.172413792
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.856539168306701
Rule of 40 score: 0
Financial ratios for ILI.V — quarterly report dated 2025-01-31
Total revenue: 0
Operating income: -113208.27586206897
Net income: -131766.89655172414
Capital expenditures: 113340
Operating cash flow: -120440.68965517242
Net tangible assets: 12477311.724137932
Owner earnings: -245106.89655172414
Return on net tangible assets (%): -1.9644207179464277
Buffett classification: The Gruesome
Stock price: 0.013793103448275864
Shares outstanding: 340628030
Book value: 12477311.724137932
P/B ratio: 0.3765488719884511
Market cap (USD): 4698317.655172414
Debt to equity: 0
Current ratio: 0.8418187856082855
Quick ratio: 0.8418187856082855
Free cash flow (dilution-adjusted): -127014.4827586207
Buyback yield (%): 0
Retained earnings: -17071595.172413792
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.9073130363735513
Rule of 40 score: 0
Financial ratios for ILI.V — quarterly report dated 2025-04-30
Total revenue: 0
Operating income: -105655.79710144928
Net income: -87166.66666666667
Capital expenditures: 0
Operating cash flow: -215573.18840579712
Net tangible assets: 14409718.84057971
Owner earnings: -87166.66666666667
Return on net tangible assets (%): -0.604915804610938
Buffett classification: The Gruesome
Stock price: 0.014492753623188408
Shares outstanding: 340628030
Book value: 14409718.84057971
P/B ratio: 0.34259087013133044
Market cap (USD): 4936638.115942029
Debt to equity: 0
Current ratio: 4.184769693490463
Quick ratio: 4.184769693490463
Free cash flow (dilution-adjusted): -215573.18840579712
Buyback yield (%): 0
Retained earnings: -18024712.318840582
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.733225944727723
Rule of 40 score: 0
Financial ratios for ILI.V — quarterly report dated 2025-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.021739130434782608
Shares outstanding: 340628030
Market cap (USD): 7404957.173913043
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ILI.V — quarterly report dated 2025-10-31
Total revenue: 0
Operating income: -94891.42857142858
Net income: -2529.285714285714
Capital expenditures: 0
Operating cash flow: -66278.57142857143
Net tangible assets: 14240195
Owner earnings: -2529.285714285714
Return on net tangible assets (%): -0.017761594657135765
Buffett classification: The Gruesome
Stock price: 0.02142857142857143
Shares outstanding: 340628030
Book value: 14240195.000000002
P/B ratio: 0.5125752892729749
Market cap (USD): 7299172.071428572
Debt to equity: 0
Current ratio: 4.412950052118043
Quick ratio: 4.412950052118043
Free cash flow (dilution-adjusted): 221394.28571428574
Buyback yield (%): 0
Retained earnings: -17730887.142857146
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6663632665945134
Rule of 40 score: 0
Financial ratios for ILI.V — annual report dated 2026-01-31
Total revenue: 0
Operating income: -527034.8148148148
Net income: -238086.66666666666
Capital expenditures: 0
Operating cash flow: -476125.18518518517
Net tangible assets: 14728507.407407407
Owner earnings: -238086.66666666666
Return on net tangible assets (%): -1.6165023384985076
Buffett classification: The Gruesome
Stock price: 0.02222222222222222
Shares outstanding: 340628030
Book value: 14728507.407407405
P/B ratio: 0.5139361082828288
Market cap (USD): 7569511.777777777
Debt to equity: 0
Current ratio: 4.261686495937345
Quick ratio: 4.261686495937345
Free cash flow (dilution-adjusted): -1460242.222222222
Buyback yield (%): 0
Retained earnings: -18574244.444444444
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.5783314645294837
Rule of 40 score: 0
Financial ratios for ILI.V — quarterly report dated 2026-01-31
Total revenue: 0
Operating income: -227690.37037037036
Net income: -186657.77777777775
Capital expenditures: 0
Operating cash flow: -54316.29629629629
Net tangible assets: 14728507.407407407
Owner earnings: -186657.77777777775
Return on net tangible assets (%): -1.267323107594066
Buffett classification: The Gruesome
Stock price: 0.02222222222222222
Shares outstanding: 340628030
Book value: 14728507.407407405
P/B ratio: 0.5139361082828288
Market cap (USD): 7569511.777777777
Debt to equity: 0
Current ratio: 4.261686495937345
Quick ratio: 4.261686495937345
Free cash flow (dilution-adjusted): -890877.7777777778
Buyback yield (%): 0
Retained earnings: -18574244.444444444
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.5459161208409895
Rule of 40 score: 0
Financial ratios for JBH.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 29.097744360902258
Shares outstanding: 109333981
Market cap (USD): 3181372229.0977445
Buyback yield (%): 0.24106493613624858
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JBH.AX — annual report dated 2022-06-30
Total revenue: 6366896551.724138
Gross profit: 1434758620.6896553
Operating income: 398344827.5862069
Net income: 375793103.44827586
Capital expenditures: 39586206.89655173
Depreciation & amortization: 148137931.03448278
Net tangible assets: 171655172.41379312
Owner earnings: 484344827.5862069
Return on net tangible assets (%): 282.1615106468461
Capex to operating income (%): 9.937673130193907
Buffett classification: The Great
Stock price: 21.413793103448278
P/E ratio: 6.23017087548174
Shares outstanding: 109333981
Book value: 882965517.2413793
P/B ratio: 2.651581746504726
Market cap (USD): 2341255248.310345
Debt to equity: 0.47207685698664376
Current ratio: 1.0906376789405192
Quick ratio: 0.22154175916711324
Effective tax rate (%): 29.717528698568294
Interest coverage ratio: 412.57142857142856
COGS to revenue (%): 77.46533795493934
SG&A to revenue (%): 13.276646447140381
Free cash flow (dilution-adjusted): 392965517.2413793
Buyback yield (%): 7.364160453153374
Retained earnings: 628068965.5172414
Inventory turnover: 6.299304148683167
Receivables turnover: 69.62292609351434
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.135787828149425
FCF margin (%): 6.1720103986135175
Rule of 40 score: 6.1720103986135175
Financial ratios for JBH.AX — annual report dated 2023-06-30
Total revenue: 6375099337.748344
Gross profit: 1445364238.4105961
Operating income: 359933774.8344371
Net income: 347417218.54304636
Capital expenditures: 47483443.70860927
Depreciation & amortization: 147218543.0463576
Net tangible assets: 257086092.71523178
Owner earnings: 447152317.8807947
Return on net tangible assets (%): 173.93096342091704
Capex to operating income (%): 13.192272309107636
Buffett classification: The Great
Stock price: 25.33774834437086
P/E ratio: 7.973919392032023
Shares outstanding: 109333981
Book value: 940132450.331126
P/B ratio: 2.946687879022259
Market cap (USD): 2770276896.066225
Debt to equity: 0.4614680191603268
Current ratio: 1.1809435395392016
Quick ratio: 0.30247278251329235
Effective tax rate (%): 29.78182304912328
Interest coverage ratio: 123.52272727272727
COGS to revenue (%): 77.32797307404637
SG&A to revenue (%): 13.983420593368237
Free cash flow (dilution-adjusted): 426754966.8874172
Buyback yield (%): 0
Retained earnings: 705231788.0794702
Inventory turnover: 7.151407435872803
Receivables turnover: 65.70921501706485
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.512195121951216
FCF margin (%): 6.694091249065071
Revenue growth (%): 0.12883491914101963
Rule of 40 score: 6.822926168206091
Financial ratios for JBH.AX — annual report dated 2024-06-30
Total revenue: 6394933333.333333
Gross profit: 1426933333.3333333
Operating income: 273466666.6666667
Net income: 292533333.3333333
Capital expenditures: 49600000
Depreciation & amortization: 156800000
Net tangible assets: 351800000
Owner earnings: 399733333.3333333
Return on net tangible assets (%): 113.62516581390942
Capex to operating income (%): 18.13749390541199
Buffett classification: The Great
Stock price: 37.513333333333335
P/E ratio: 14.020563151481314
Shares outstanding: 109333981
Book value: 1039400000
P/B ratio: 3.946009307209288
Market cap (USD): 4101482073.9133334
Debt to equity: 0.42165351805528833
Current ratio: 1.2101769911504425
Quick ratio: 0.3758773268233141
Effective tax rate (%): 30.060567421102963
Interest coverage ratio: 227.8888888888889
COGS to revenue (%): 77.68650181393603
SG&A to revenue (%): 14.753346399232726
Free cash flow (dilution-adjusted): 452066666.6666667
Buyback yield (%): 0
Retained earnings: 812200000
Inventory turnover: 6.814191660570593
Receivables turnover: 71.0022205773501
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.852835738578914
FCF margin (%): 7.069138067636879
Revenue growth (%): 0.3111166514307818
Rule of 40 score: 7.38025471906766
Financial ratios for KHANDSE.NS — annual report dated 2022-03-31
Capital expenditures: 3912.0400896742713
Buffett classification: The Gruesome
Stock price: 0.2710009231174997
Shares outstanding: 15253805
Market cap (USD): 4133795.236054332
Buyback yield (%): 0
Retained earnings: -8508.901490175393
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KHANDSE.NS — annual report dated 2023-03-31
Total revenue: 764518.5140073082
Gross profit: 464092.20462850184
Operating income: 76107.4299634592
Net income: 53985.87088915957
Capital expenditures: 71987.08891595616
Operating cash flow: -881286.8453105969
Depreciation & amortization: 35928.13641900122
Net tangible assets: 3240991.108404385
Owner earnings: 17926.91839220462
Return on net tangible assets (%): 0.5531307489772923
Capex to operating income (%): 94.58615137906864
Buffett classification: The Gruesome
Stock price: 0.27527405602923266
P/E ratio: 77.77918005342671
Shares outstanding: 15253805
Book value: 3592249.330085262
P/B ratio: 1.1688990341127927
Market cap (USD): 4198976.77222899
Debt to equity: 0.08956632745008225
Current ratio: 1.8735013907320375
Quick ratio: 1.8735013907320375
Effective tax rate (%): 10.777574014167723
Interest coverage ratio: 2.187645952881946
COGS to revenue (%): 39.29614572760163
SG&A to revenue (%): 10.527017633637564
Free cash flow (dilution-adjusted): -953273.9342265531
Buyback yield (%): 0
Retained earnings: 45809.13520097442
Receivables turnover: 0.8007549683777735
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9365731851487464
FCF margin (%): -124.68945051832199
Rule of 40 score: -124.68945051832199
Financial ratios for KHANDSE.NS — annual report dated 2024-03-31
Total revenue: 1022556.6614702003
Gross profit: 639114.5221249551
Operating income: 146687.25266818563
Net income: 20853.69948435064
Capital expenditures: 43081.424631250746
Operating cash flow: -208919.1749610265
Depreciation & amortization: 37581.244753567575
Net tangible assets: 3220896.8701283126
Owner earnings: 15353.519606667469
Return on net tangible assets (%): 0.4766846076029694
Capex to operating income (%): 29.369576324878903
Buffett classification: The Good
Stock price: 0.3520873320537428
P/E ratio: 257.5404671074495
Shares outstanding: 15253805
Book value: 3559334.8123276173
P/B ratio: 1.5088975298184737
Market cap (USD): 5370671.506118042
Debt to equity: 0.05214142793577086
Current ratio: 1.0117093481415573
Quick ratio: 1.0117093481415573
Effective tax rate (%): -6.172575691896282
Interest coverage ratio: 5.711867572552591
COGS to revenue (%): 37.498375766673306
SG&A to revenue (%): 19.757748824336524
Free cash flow (dilution-adjusted): -252000.59959227726
Buyback yield (%): 0
Retained earnings: 67756.20578006955
Receivables turnover: 1.2827926672116505
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9016159638665178
FCF margin (%): -24.64416976463276
Revenue growth (%): 33.751719904120655
Rule of 40 score: 9.107550139487895
Financial ratios for KHANDSE.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 3297169.1352126137
Buffett classification: The Gruesome
Stock price: 0.3729096989966555
Shares outstanding: 15253805
Book value: 3630625.895843287
P/B ratio: 1.5667523987024436
Market cap (USD): 5688291.831103679
Debt to equity: 0.013607232625774783
Current ratio: 1.0777685439490834
Quick ratio: 1.0777685439490834
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KHANDSE.NS — quarterly report dated 2025-03-31
Total revenue: 138099.13490764552
Gross profit: 46726.67757774141
Operating income: -156979.1910217442
Net income: -240109.89010989008
Capital expenditures: 0
Depreciation & amortization: 12730.886135141453
Net tangible assets: 3054163.0815992514
Owner earnings: -227379.00397474863
Return on net tangible assets (%): -7.444887450335042
Buffett classification: The Gruesome
Stock price: 0.24460263741393395
Shares outstanding: 15253805
Book value: 3377303.3668459198
P/B ratio: 1.1047633358096478
Market cap (USD): 3731120.933597853
Debt to equity: 0.05203321087457073
Current ratio: 1.4785914761944785
Quick ratio: 1.4785914761944785
Interest coverage ratio: -47.7864768683274
COGS to revenue (%): 66.16439515787692
Buyback yield (%): 0
Retained earnings: -26516.36661211129
Receivables turnover: 0.30493833343056526
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.39667676983348
Rule of 40 score: 0
Financial ratios for KHANDSE.NS — annual report dated 2025-03-31
Total revenue: 1115185.8779518353
Gross profit: 751052.1393500116
Operating income: -614601.3560907177
Net income: -93570.25952770632
Capital expenditures: 414274.0238484919
Operating cash flow: 470388.1225157821
Depreciation & amortization: 40133.27098433481
Net tangible assets: 3054163.0815992514
Owner earnings: -467711.0123918634
Return on net tangible assets (%): -15.31388468447323
Buffett classification: The Gruesome
Stock price: 0.24460263741393395
Shares outstanding: 15253805
Book value: 3377303.3668459198
P/B ratio: 1.1047633358096478
Market cap (USD): 3731120.933597853
Debt to equity: 0.05203321087457073
Current ratio: 1.4785914761944785
Quick ratio: 1.4785914761944785
Effective tax rate (%): 456.366874443455
Interest coverage ratio: -48.45437788018433
COGS to revenue (%): 32.65229104860944
SG&A to revenue (%): 40.35040306940761
Free cash flow (dilution-adjusted): 470388.1225157821
Buyback yield (%): 0
Retained earnings: -26516.36661211129
Receivables turnover: 2.4624551291748
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.213768827856384
FCF margin (%): 42.180243833404965
Revenue growth (%): 9.058590097927247
Rule of 40 score: 51.23883393133221
Financial ratios for KHANDSE.NS — quarterly report dated 2025-06-30
Total revenue: 133629.7683126609
Gross profit: 31710.74186754037
Operating income: -82073.48467119121
Net income: -68570.09127076996
Capital expenditures: 0
Depreciation & amortization: 8038.848584132928
Owner earnings: -60531.24268663703
Buffett classification: The Gruesome
Stock price: 0.2752164755441142
Shares outstanding: 15253805
Market cap (USD): 4198098.450737187
Interest coverage ratio: -17.191176470588236
COGS to revenue (%): 76.26970227670753
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -3.236346554939351
Rule of 40 score: -3.236346554939351
Financial ratios for KHANDSE.NS — quarterly report dated 2025-09-30
Total revenue: 383077.7903043968
Gross profit: 278455.4678692221
Operating income: 10496.054114994362
Net income: 27418.26381059752
Capital expenditures: 0
Depreciation & amortization: 8478.015783540022
Net tangible assets: 2909605.411499436
Owner earnings: 35896.279594137544
Return on net tangible assets (%): 1.2337164157128357
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.266065388951522
P/E ratio: 37.00553022203947
Shares outstanding: 15253805
Book value: 3218331.4543404733
P/B ratio: 1.2610601542740643
Market cap (USD): 4058509.560315671
Debt to equity: 0.1003131721465954
Current ratio: 1.556333765239708
Quick ratio: 1.556333765239708
Effective tax rate (%): 0.04110152075626798
Interest coverage ratio: 1.6624999999999999
COGS to revenue (%): 27.310986197357195
Buyback yield (%): 0
Receivables turnover: 0.224279387206854
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.29415760654919315
Revenue growth (%): 186.67099789329032
Rule of 40 score: 186.67099789329032
Financial ratios for KHANDSE.NS — quarterly report dated 2025-12-31
Total revenue: 117555.97638409269
Gross profit: 17310.905647766514
Operating income: -121610.78311239836
Net income: -54328.840369834026
Capital expenditures: 0
Depreciation & amortization: 9424.083769633507
Owner earnings: -44904.75660020052
Buffett classification: The Gruesome
Stock price: 0.2289183468864877
Shares outstanding: 15253805
Market cap (USD): 3491875.8243288407
Interest coverage ratio: -17.38375796178344
COGS to revenue (%): 85.27432957452858
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -69.31276639904345
Rule of 40 score: -69.31276639904345
Financial ratios for MA.TO — quarterly report dated 2025-12-31
Total revenue: 6427737226.277371
Gross profit: 5100729927.007298
Operating income: 3743795620.437956
Net income: 2963503649.6350365
Capital expenditures: 81751824.81751825
Operating cash flow: 3651094890.5109487
Depreciation & amortization: 216788321.1678832
Net tangible assets: -5384671532.846715
Owner earnings: 3098540145.9854016
Return on net tangible assets (%): -57.54371695811306
Capex to operating income (%): 2.1836615324624686
Buffett classification: The Great
Stock price: 25.43795620437956
P/E ratio: 44.96026458557275
Shares outstanding: 19059893404
Book value: 5654014598.540142
P/B ratio: 85.75229604045964
Market cap (USD): 484844733671.09485
Debt to equity: 2.4528789052414166
Current ratio: 1.0349705649767156
Quick ratio: 1.0349705649767156
Effective tax rate (%): 16.735028712059062
Interest coverage ratio: 32.257861635220124
COGS to revenue (%): 20.645014762661823
SG&A to revenue (%): 17.737905973200093
Free cash flow (dilution-adjusted): 3357664233.576642
Buyback yield (%): 0.5356519544528228
Retained earnings: 62069343065.69343
Receivables turnover: 1.9106096767194618
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.336996336996336
FCF margin (%): 52.23711106064047
Revenue growth (%): 3.866016560399277
Rule of 40 score: 56.10312762103975
Financial ratios for MA.TO — annual report dated 2025-12-31
Total revenue: 23935036496.350365
Gross profit: 18642335766.423355
Operating income: 14243795620.437956
Net income: 10925547445.255474
Capital expenditures: 356934306.56934303
Operating cash flow: 12881751824.817516
Depreciation & amortization: 834306569.3430656
Net tangible assets: -5384671532.846715
Owner earnings: 11402919708.029196
Return on net tangible assets (%): -211.76630066422666
Capex to operating income (%): 2.5058932048785487
Buffett classification: The Great
Stock price: 25.43795620437956
P/E ratio: 44.37715694343933
Shares outstanding: 19059893404
Book value: 5654014598.540142
P/B ratio: 85.75229604045964
Market cap (USD): 484844733671.09485
Debt to equity: 2.4528789052414166
Current ratio: 1.0349705649767156
Quick ratio: 1.0349705649767156
Effective tax rate (%): 19.431585746581977
Interest coverage ratio: 27.027700831024934
COGS to revenue (%): 22.11277484675673
SG&A to revenue (%): 14.8912811442164
Free cash flow (dilution-adjusted): 11559124087.59124
Buyback yield (%): 1.7654835497100203
Retained earnings: 62069343065.69343
Receivables turnover: 7.1145584725537
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 62.156394330307386
FCF margin (%): 48.29373913573846
Revenue growth (%): 21.514901089150502
Rule of 40 score: 69.80864022488896
Financial ratios for MDA.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.480314960629921
Shares outstanding: 161919141
Market cap (USD): 1211206172.8346457
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MDA.TO — annual report dated 2022-12-31
Total revenue: 471470588.2352941
Gross profit: 167941176.47058824
Operating income: 54852941.176470585
Net income: 19338235.294117644
Capital expenditures: 101323529.4117647
Operating cash flow: 41911764.70588235
Depreciation & amortization: 56029411.76470588
Net tangible assets: 20808823.529411763
Owner earnings: -25955882.35294117
Return on net tangible assets (%): -124.73498233215545
Capex to operating income (%): 184.71849865951742
Buffett classification: The Gruesome
Stock price: 4.705882352941177
P/E ratio: 39.40237651711027
Shares outstanding: 161919141
Book value: 735735294.117647
P/B ratio: 1.0356611057365581
Market cap (USD): 761972428.2352941
Debt to equity: 0.2517489506296222
Current ratio: 1.18706842435656
Quick ratio: 1.1635279347143754
Effective tax rate (%): 23.099415204678362
Interest coverage ratio: 5.525925925925926
COGS to revenue (%): 64.3792888334373
R&D to revenue (%): 5.11540860885839
SG&A to revenue (%): 10.68309419837804
Free cash flow (dilution-adjusted): -96764705.88235293
Buyback yield (%): 0
Retained earnings: 7279411.7647058815
Inventory turnover: 55.04
Receivables turnover: 2.0577663671373556
Capitalized R&D asset: 24117647.058823526
ROCI (R&D-adjusted, %): 6.584755403868031
FCF margin (%): -20.524017467248907
Rule of 40 score: -20.524017467248907
Financial ratios for MDA.TO — annual report dated 2023-12-31
Total revenue: 611818181.8181818
Gross profit: 184848484.84848484
Operating income: 58712121.21212121
Net income: 36969696.96969697
Capital expenditures: 112121212.12121211
Operating cash flow: 10227272.727272727
Depreciation & amortization: 59166666.666666664
Net tangible assets: 32121212.12121212
Owner earnings: -15984848.484848484
Return on net tangible assets (%): -49.764150943396224
Capex to operating income (%): 190.96774193548384
Buffett classification: The Gruesome
Stock price: 8.727272727272727
P/E ratio: 38.22353492459016
Shares outstanding: 161919141
Book value: 806590909.090909
P/B ratio: 1.7519568933220626
Market cap (USD): 1413112503.2727273
Debt to equity: 0.4930966469428008
Current ratio: 1.2234726688102895
Quick ratio: 1.1969453376205788
Effective tax rate (%): 27.488855869242197
Interest coverage ratio: 9.011627906976745
COGS to revenue (%): 69.78702327885092
R&D to revenue (%): 4.86627043090639
SG&A to revenue (%): 9.9925705794948
Free cash flow (dilution-adjusted): -143712121.2121212
Buyback yield (%): 0
Retained earnings: 44469696.96969697
Inventory turnover: 56.92929292929293
Receivables turnover: 2.0195048762190546
Capitalized R&D asset: 45931550.80213903
ROCI (R&D-adjusted, %): 5.034164880876867
Rosenberg metric: 0.7010347376201033
FCF margin (%): -23.489351163942544
Revenue growth (%): 29.768048545341113
Rule of 40 score: 6.278697381398569
Financial ratios for MDA.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.874074074074073
Shares outstanding: 161919141
Market cap (USD): 2084559015.2444444
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MDA.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.650349650349654
Shares outstanding: 161919141
Market cap (USD): 3343686876.7342663
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MDA.TO — annual report dated 2024-12-31
Total revenue: 755314685.3146853
Gross profit: 196993006.993007
Operating income: 74685314.68531469
Net income: 55524475.52447553
Capital expenditures: 98741258.74125874
Operating cash flow: 568321678.3216784
Depreciation & amortization: 63636363.63636364
Net tangible assets: 108391608.3916084
Owner earnings: 20419580.41958043
Return on net tangible assets (%): 18.838709677419363
Capex to operating income (%): 132.20973782771534
Buffett classification: The Gruesome
Stock price: 20.650349650349654
P/E ratio: 60.220053321536525
Shares outstanding: 161919141
Book value: 822377622.3776225
P/B ratio: 4.065877749770409
Market cap (USD): 3343686876.7342663
Debt to equity: 0.11632653061224489
Current ratio: 0.574243813015582
Quick ratio: 0.5668194317140238
Effective tax rate (%): 28.468468468468473
Interest coverage ratio: 3.814285714285714
COGS to revenue (%): 73.91908156652163
R&D to revenue (%): 3.416350337931673
SG&A to revenue (%): 8.425145819831497
Free cash flow (dilution-adjusted): 417762237.7622378
Buyback yield (%): 0
Retained earnings: 96993006.993007
Inventory turnover: 98.56790123456791
Receivables turnover: 2.8423684210526314
Capitalized R&D asset: 53710746.60633484
ROCI (R&D-adjusted, %): 6.676677177712552
Rosenberg metric: 0.40790761401448483
FCF margin (%): 55.30969354689381
Revenue growth (%): 23.45410904103328
Rule of 40 score: 78.76380258792709
Financial ratios for MDA.TO — quarterly report dated 2025-03-31
Total revenue: 245454545.45454547
Gross profit: 55734265.73426574
Operating income: 24685314.685314685
Net income: 23006993.006993007
Capital expenditures: 27832167.832167834
Operating cash flow: 186713286.71328673
Depreciation & amortization: 17692307.692307692
Net tangible assets: 131328671.32867134
Owner earnings: 12867132.867132865
Return on net tangible assets (%): 9.797657082002127
Capex to operating income (%): 112.74787535410766
Buffett classification: The Gruesome
Stock price: 19.223776223776223
P/E ratio: 33.823382873024315
Shares outstanding: 161919141
Book value: 849790209.7902098
P/B ratio: 3.6629009102123105
Market cap (USD): 3112697332.93007
Debt to equity: 0.11364384463462805
Current ratio: 0.6504394344669469
Quick ratio: 0.6409629346580054
Effective tax rate (%): 27.373068432671083
Interest coverage ratio: 7.20408163265306
COGS to revenue (%): 77.29344729344729
R&D to revenue (%): 1.566951566951567
SG&A to revenue (%): 7.777777777777777
Free cash flow (dilution-adjusted): 141608391.6083916
Buyback yield (%): 0
Retained earnings: 120000000
Inventory turnover: 21.879032258064516
Receivables turnover: 0.8972392638036811
Capitalized R&D asset: 3846153.8461538465
ROCI (R&D-adjusted, %): 2.517551793944093
FCF margin (%): 57.692307692307686
Rule of 40 score: 57.692307692307686
Financial ratios for MDA.TO — quarterly report dated 2025-06-30
Total revenue: 272481751.8248175
Gross profit: 69197080.2919708
Operating income: 31824817.518248174
Net income: 19854014.598540146
Capital expenditures: 34233576.642335765
Operating cash flow: 38540145.98540146
Depreciation & amortization: 18686131.386861313
Net tangible assets: 185328467.15328467
Owner earnings: 4306569.343065694
Return on net tangible assets (%): 2.3237495076801897
Capex to operating income (%): 107.56880733944953
Buffett classification: The Gruesome
Stock price: 25.627737226277368
P/E ratio: 96.81576400730387
Shares outstanding: 161919141
Book value: 935985401.4598539
P/B ratio: 4.433425127123138
Market cap (USD): 4149621197.452554
Debt to equity: 0.30499883022693597
Current ratio: 0.8645106250969443
Quick ratio: 0.8539630836047775
Effective tax rate (%): 24.022346368715084
Interest coverage ratio: 15.03448275862069
COGS to revenue (%): 74.60487543530672
R&D to revenue (%): 1.6072863648540048
SG&A to revenue (%): 8.974015537101527
Free cash flow (dilution-adjusted): -14233576.642335765
Buyback yield (%): 0
Retained earnings: 145109489.0510949
Inventory turnover: 20.477941176470587
Receivables turnover: 1.0026860059092129
Capitalized R&D asset: 6956485.120718697
ROCI (R&D-adjusted, %): 2.4426069675435476
Rosenberg metric: 3.500331785003317
FCF margin (%): -5.223680685775516
Revenue growth (%): 11.011084076777484
Rule of 40 score: 5.787403391001968
Financial ratios for MDA.TO — quarterly report dated 2025-09-30
Total revenue: 294820143.8848921
Gross profit: 77769784.17266187
Operating income: 23812949.64028777
Net income: 17553956.834532376
Capital expenditures: 35827338.1294964
Operating cash flow: 23597122.302158274
Depreciation & amortization: 31223021.582733814
Net tangible assets: -256043165.46762592
Owner earnings: 12949640.287769787
Return on net tangible assets (%): -5.057600449564485
Capex to operating income (%): 150.45317220543805
Buffett classification: The Gruesome
Stock price: 24.93525179856115
P/E ratio: 66.82937893387506
Shares outstanding: 161919141
Book value: 956330935.2517984
P/B ratio: 4.2218591943579336
Market cap (USD): 4037494551.8417263
Debt to equity: 0.32445648085458517
Current ratio: 0.5543005472148168
Quick ratio: 0.5420232917075908
Effective tax rate (%): 37.11340206185567
Interest coverage ratio: 5.910714285714286
COGS to revenue (%): 73.62127867252319
R&D to revenue (%): 2.903855539287458
SG&A to revenue (%): 8.077110785749147
Free cash flow (dilution-adjusted): -29280575.53956835
Buyback yield (%): 0
Retained earnings: 160575539.56834534
Inventory turnover: 17.24
Receivables turnover: 0.8057412504915454
Capitalized R&D asset: 12764688.417710528
ROCI (R&D-adjusted, %): 1.795788791146779
Rosenberg metric: 1.9574340527577936
FCF margin (%): -9.931673987310884
Revenue growth (%): 8.19812406169361
Rule of 40 score: -1.7335499256172735
Financial ratios for MDA.TO — quarterly report dated 2025-12-31
Total revenue: 364306569.3430657
Gross profit: 92773722.62773722
Operating income: 33430656.934306566
Net income: 17518248.17518248
Capital expenditures: 28321167.883211676
Operating cash flow: 40072992.70072992
Depreciation & amortization: 33795620.4379562
Net tangible assets: -235109489.05109486
Owner earnings: 22992700.729927
Return on net tangible assets (%): -9.779571561626822
Capex to operating income (%): 84.71615720524017
Buffett classification: The Gruesome
Stock price: 19.445255474452555
P/E ratio: 40.40073490224467
Shares outstanding: 161919141
Book value: 989051094.8905108
P/B ratio: 3.183413960324724
Market cap (USD): 3148559062.948905
Debt to equity: 0.3033948339483395
Current ratio: 0.4663074821672485
Quick ratio: 0.4484747306116254
Effective tax rate (%): 26.153846153846157
Interest coverage ratio: 12.722222222222223
COGS to revenue (%): 74.53416149068323
R&D to revenue (%): 2.945301542776998
SG&A to revenue (%): 7.072730915648166
Free cash flow (dilution-adjusted): -16788321.16788321
Buyback yield (%): 0
Retained earnings: 180437956.20437956
Inventory turnover: 15.829787234042552
Receivables turnover: 1.294010889292196
Capitalized R&D asset: 17911153.704773407
ROCI (R&D-adjusted, %): 2.4087200349977396
Rosenberg metric: 1.7525608783659443
FCF margin (%): -4.608294930875576
Revenue growth (%): 23.56909013832632
Rule of 40 score: 18.960795207450744
Financial ratios for MDA.TO — annual report dated 2025-12-31
Total revenue: 1192116788.3211677
Gross profit: 299051094.8905109
Operating income: 115182481.75182481
Net income: 79197080.29197079
Capital expenditures: 127956204.37956204
Operating cash flow: 297445255.47445256
Depreciation & amortization: 102627737.22627737
Net tangible assets: -235109489.05109486
Owner earnings: 53868613.138686106
Return on net tangible assets (%): -22.91213908723998
Capex to operating income (%): 111.08998732572877
Buffett classification: The Gruesome
Stock price: 19.445255474452555
P/E ratio: 39.75599922801844
Shares outstanding: 161919141
Book value: 989051094.8905108
P/B ratio: 3.183413960324724
Market cap (USD): 3148559062.948905
Debt to equity: 0.3033948339483395
Current ratio: 0.4663074821672485
Quick ratio: 0.4484747306116254
Effective tax rate (%): 28.805774278215225
Interest coverage ratio: 9.28235294117647
COGS to revenue (%): 74.91427871662994
R&D to revenue (%): 2.3328434974283616
SG&A to revenue (%): 7.910849865295126
Free cash flow (dilution-adjusted): 87080291.9708029
Buyback yield (%): 0
Retained earnings: 180437956.20437956
Inventory turnover: 52.06382978723404
Receivables turnover: 4.234379051075965
Capitalized R&D asset: 54924030.166913375
ROCI (R&D-adjusted, %): 7.46671285868277
Rosenberg metric: 3.9550966312582814
FCF margin (%): 7.304677932892481
Revenue growth (%): 57.83047933517913
Rule of 40 score: 65.13515726807161
Financial ratios for MEK.AX — annual report dated 2021-06-30
Operating income: -2607348.872180451
Net income: -2586626.3157894737
Capital expenditures: 6058928.571428571
Net tangible assets: 14225847.368421052
Owner earnings: -8645554.887218045
Return on net tangible assets (%): -60.77356703833122
Buffett classification: The Gruesome
Stock price: 0.045112781954887216
Shares outstanding: 2984138192
Book value: 14225847.368421054
P/B ratio: 9.463251790384515
Market cap (USD): 134622775.57894737
Debt to equity: 0
Current ratio: 11.199867810097457
Quick ratio: 11.199867810097457
Free cash flow (dilution-adjusted): -7797245.112781955
Buyback yield (%): 0.5515026095011353
Retained earnings: -28023797.7443609
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.711481074858577
Rule of 40 score: 0
Financial ratios for MEK.AX — annual report dated 2022-06-30
Operating income: -2090795.8620689656
Net income: -2064537.9310344828
Capital expenditures: 43436.551724137935
Depreciation & amortization: 33284.8275862069
Net tangible assets: 12412711.034482758
Owner earnings: -2074689.655172414
Return on net tangible assets (%): -16.714234701902626
Buffett classification: The Gruesome
Stock price: 0.034482758620689655
Shares outstanding: 2984138192
Book value: 12412711.03448276
P/B ratio: 8.289995366818362
Market cap (USD): 102901316.96551724
Debt to equity: 0.007245964939943931
Current ratio: 2.6134147522367215
Quick ratio: 2.6134147522367215
Free cash flow (dilution-adjusted): -4341543.448275862
Buyback yield (%): 0.01197129546338382
Retained earnings: -27769124.827586208
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.26653790807508
Rule of 40 score: 0